1.4848
前日終値:
$1.48
開ける:
$1.48
24時間の取引高:
226.85K
Relative Volume:
0.21
時価総額:
$4.12M
収益:
$1.41M
当期純損益:
$-7.36M
株価収益率:
-0.1404
EPS:
-10.5747
ネットキャッシュフロー:
$-7.07M
1週間 パフォーマンス:
+6.67%
1か月 パフォーマンス:
-7.73%
6か月 パフォーマンス:
-64.19%
1年 パフォーマンス:
-81.29%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
名前
60 Degrees Pharmaceuticals Inc
セクター
電話
202-327-5422
住所
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.55 | 3.94M | 1.41M | -7.36M | -7.07M | -10.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc (SXTP) 最新ニュース
60 Degrees Pharmaceuticals enrolls first patient in babesiosis trial - Investing.com
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis - Stock Titan
60 Degrees Pharma Nears FDA Deadline in Thin Holiday Trading - Bez Kabli
60 Degrees Pharmaceuticals (SXTP) Holds Near Support After Minor DeclineFlat Correction - Newser
60 Degrees Pharmaceuticals (SXTP) Dips 1.34% as Shares Test Support LevelSupport Level Bounce - Newser
60 Degrees Pharmaceuticals, Inc.Warrant (NQ: SXTPW - The Chronicle-Journal
SXTP Stock Price, Quote & Chart | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill
SXTP Downgraded by HC Wainwright & Co. -- New Rating: Neutral - GuruFocus
60 Degrees Pharm Cut to Neutral From Buy by HC Wainwright & Co. - Moomoo
H.C. Wainwright Downgrades 60 Degrees Pharmaceuticals(SXTP.US) to Hold Rating - Moomoo
60 Degrees Pharmaceuticals (NASDAQ: SXTP) director files initial Form 3 insider report - Stock Titan
60 Degrees Pharmaceuticals, Inc. Files Form 8-K with SEC – Company Details, NASDAQ Listing, and Compliance Highlights - Minichart
60 Degrees Pharmaceuticals appoints Eric Francois to board of directors - Investing.com
60 Degrees Pharmaceuticals appoints Eric Francois to board - TradingView
Eric Francois joins 60 Degrees Pharmaceuticals (SXTP) board with deep biotech finance background - Stock Titan
Knight Therapeutics (TSX: GUD) reports exit from SXTP, 0 shares as of Mar 31, 2026 - Stock Titan
60 Degrees Pharmaceuticals, Inc. Q1 2026 Financial Results: Net Loss, Operating Expenses, and Key Financial Highlights - Minichart
CVI/Heights report 7.0% stake in 60 Degrees (NASDAQ: SXTP) - Stock Titan
60 Degrees Pharmaceuticals Releases Q1 2026 Financial Results - AlphaStreet
60 Degrees Pharm 1Q Rev $162,000 >SXTP - Moomoo
Tiny $162K sales, $2.21M loss: 60 Degrees Pharma Q1 2026 - Stock Titan
60 Degrees Pharmaceuticals 1Q 2026: Revenue $162.09K, EPS ($1.28) — 10-Q Summary - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) posts Q1 2026 loss and flags going concern risk - Stock Titan
MSN Money - MSN
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
TradingKey - TradingKey
60 Degrees reports shared 9.1% stake (SXTP) from warrants and holdings - Stock Titan
SXTP Q1'26 Earnings: EPS estimate is (0.76) USD - TradingView
60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split - ChartMill
The biggest catalyst for 60 Degrees (SXTP) nobody is watching (Momentum Fading) 2026-05-08Late Breakout - Newser
60 Degrees Pharmaceuticals (SXTP) price target decreased by 19.89% to 14.38 - MSN
60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Quantisnow
60 Degrees Pharmaceuticals Inc. (SXTP) upgraded to buy: Here's what you should know - MSN
Analysts Are Bullish on Top Healthcare Stocks: IGC Pharma (IGC), 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
60 Degrees Pharma announces 1-for-4 reverse stock split; shares up - MSN
60 Degrees Pharmaceuticals shares slide after Nasdaq flags delisting risk - MSN
Is 60 Degrees (SXTP) stock holding key zones | Q4 2025: EPS Misses ViewsNCAV - Newser
60 Degrees (SXTP) Stock: Investment Potential Review (Tick Up) 2026-04-20Trending Entry Points - Xã Châu Thành
60 Degrees Pharmaceuticals, Inc. Partners with Runway Health to Offer ARAKODA® for Convenient Online Malaria Prevention - Quiver Quantitative
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website - The Manila Times
Once-weekly malaria preventive moves online for U.S. travelers - Stock Titan
SXTP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
60 Degrees Pharmaceuticals, Inc. Warrant (SXTPW) - Minichart
Sentiment Review: Is 60 Degrees Pharmaceuticals Inc Equity Warrant impacted by rising ratesMarket Performance Recap & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Targets Report: Will 60 Degrees Pharmaceuticals Inc benefit from sector rotationIPO Watch & Weekly Breakout Watchlists - baoquankhu1.vn
Macro Review: Whats the fair value of 60 Degrees Pharmaceuticals Inc stockEarnings Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn
SXTPW | 60 Degrees Pharmaceuticals, Inc. Insider Trading - Quiver Quantitative
Is 60 Degrees (SXTP) Stock in a Downtrend | Price at $1.71, Down 4.75%Expert Momentum Signals - Newser
CEO Change: Is 60 Degrees Pharmaceuticals Inc Equity Warrant part of any major index2026 AllTime Highs & Verified High Yield Trade Plans - baoquankhu1.vn
60 Degrees Pharmaceuticals Announces 2025 Annual Results - ADVFN
Earnings Miss: Will 60 Degrees Pharmaceuticals Inc Equity Warrant benefit from geopolitical trends2026 Retail & AI Enhanced Trading Signals - baoquankhu1.vn
60 Degrees Pharmaceuticals Inc (SXTP) 財務データ
収益
当期純利益
現金流量
EPS
60 Degrees Pharmaceuticals Inc (SXTP) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
大文字化:
|
ボリューム (24 時間):